Status:
COMPLETED
Trial of Rifaximin in the Treatment of Tropical Enteropathy
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Baylor College of Medicine
Kamuzu University of Health Sciences
Conditions:
Tropical Enteropathy
Eligibility:
All Genders
3-5 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether rifaximin is effective in the treatment of tropical enteropathy in a population of African children at high risk for this disease.
Eligibility Criteria
Inclusion
- live in single village
Exclusion
- acutely malnourished
- acutely ill
- chronic disease
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT00858988
Start Date
September 1 2007
End Date
October 1 2007
Last Update
November 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Limela, Malawi